Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 22 | $681,110 |
Sells | 4 | $1,403,938 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Nov 2023 16:05 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 10 Nov 2023 | Sale | 440,000 | 0.2942 | 129,448 | I |
14 Nov 2023 16:05 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 10 Nov 2023 | Sale | 4,324,008 | 0.2942 | 1,272,123 | I |
28 Apr 2023 06:00 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 27 Apr 2023 | Purchase | 47,000 | 0.75 | 35,250 | D |
28 Apr 2023 06:00 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 26 Apr 2023 | Purchase | 3,999 | 0.66 | 2,639 | D |
13 Mar 2023 16:05 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 09 Mar 2023 | Purchase | 174,508 | 1.38 | 240,821 | I |
02 Mar 2023 06:24 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 01 Mar 2023 | Purchase | 4,800 | 1.52 | 7,296 | D |
02 Mar 2023 06:24 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 28 Feb 2023 | Purchase | 200 | 1.52 | 304 | D |
19 Jan 2023 06:05 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 18 Jan 2023 | Purchase | 6,800 | 1.62 | 11,016 | D |
03 Jan 2023 06:00 | TCON | Tracon Pharmaceuticals Inc | BROWN SCOTT B. | Chief Financial Officer | 29 Dec 2022 | Purchase | 3,500 | 1.49 | 5,215 | D |
19 Jan 2023 06:00 | TCON | Tracon Pharmaceuticals Inc | LARUE WILLIAM R | Director | 21 Dec 2022 | Sale | 120 | 1.2553 | 151 | D |
16 Dec 2022 17:03 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 14 Dec 2022 | Purchase | 27,500 | 1.2382 | 34,050 | I |
16 Dec 2022 17:03 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 14 Dec 2022 | Purchase | 140,000 | 1.2559 | 175,826 | I |
15 Dec 2022 06:00 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 14 Dec 2022 | Purchase | 23,000 | 1.2937 | 29,755 | D |
08 Dec 2022 18:49 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 06 Dec 2022 | Sale | 1,539 | 1.44 | 2,216 | I |
22 Nov 2022 06:00 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 18 Nov 2022 | Purchase | 13,900 | 1.41 | 19,599 | D |
04 Nov 2022 06:00 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 03 Nov 2022 | Purchase | 9,200 | 1.52 | 13,984 | D |
03 Nov 2022 06:00 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 02 Nov 2022 | Purchase | 6,000 | 1.59 | 9,540 | D |
19 Oct 2022 19:22 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 18 Oct 2022 | Purchase | 2,500 | 1.65 | 4,125 | I |
19 Oct 2022 19:22 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 18 Oct 2022 | Purchase | 10,000 | 1.65 | 16,500 | I |
11 Oct 2022 06:00 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 07 Oct 2022 | Purchase | 5,000 | 1.77 | 8,850 | D |
05 Oct 2022 06:00 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 03 Oct 2022 | Purchase | 5,000 | 1.67 | 8,350 | D |
03 Oct 2022 16:06 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 29 Sep 2022 | Purchase | 9,400 | 1.7415 | 16,370 | I |
28 Sep 2022 18:00 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 27 Sep 2022 | Purchase | 1,700 | 1.6924 | 2,877 | I |
26 Sep 2022 06:00 | TCON | Tracon Pharmaceuticals Inc | THEUER CHARLES | President and CEO | 22 Sep 2022 | Purchase | 5,000 | 1.76 | 8,800 | D |
22 Sep 2022 18:09 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 22 Sep 2022 | Purchase | 13,900 | 1.7297 | 24,043 | I |
22 Sep 2022 18:09 | TCON | Tracon Pharmaceuticals Inc | OPALEYE MANAGEMENT INC. | 10% | 22 Sep 2022 | Purchase | 3,411 | 1.7297 | 5,900 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)